Analysis of Outcomes in Sarcoma Reconstruction Using Intraoperative Fluorescence Angiography


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Jacksonville, Florida: 17-000713
    Sponsor Protocol Number: 17-000713

About this study

The primary objective of the study is to compare outcomes of patients undergoing sarcoma reconstructive surgery using fluorescence angiography with patients undergoing sarcoma reconstructive surgery without fluorescence angiograph.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Patients with the diagnosis of sarcoma having reconstructive surgery.

Exclusion Criteria: 

  • Patients with iodine allergy
  • Patients < 18 years of age
  • Patients > 90 years of age

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Antonio Forte, M.D., M.S., Ph.D.

Contact us for the latest status

Contact information:

Mauricia Buchanan R.N., C.C.R.C.



Mayo Clinic Footer